For a long time, C 2 -symmetric ligands were dominating in asymmetric catalysis. However, more recently it was found that in several metal-catalyzed processes non-symmetric mixed-donor bidentate P,N-ligands are superior to C 2 -symmetric P,P-or N,N-ligands. Especially phosphinooxazolines (PHOX ligan
11th conference of the central european division e.V. of the international isotope society
✍ Scribed by S. Pounds; M. J. Hickey; L. P. Kingston; A. N. Mather; D. J. Wilkinson; G. V. Sidorov; Yu. B. Zverkov; N. F. Myasoedov; I. L. Karpenko; E. A. Shirokova; D. M. Yanvarev; M. V. Yasko; Yu. S. Skoblov; A. B. Susan; N. F. Myasoedov; I. Y. Nagaev; V. P. Shevchenko; A. B. Susan; G. Rotert; Jens Krüger; Gregor Fels; F. Wuest; P. Mäding; J. Zessin; U. Pleiß; F. Wüst; A. J. Bloom; V. Derdau; R. Oekonomopulos; G. Schubert; H. Andres; P. Burtscher; Y. Metz; Th. Moenius; F. Kaegi; Y. Metz; I. Rodriguez; R. Ruetsch; C. G. M. Janssen; B. Verreet; H. A. C. Lenoir; J. B. A. Thijssen; Rolf P. Stuerm; Andreas Krins; E. Rausch; M. Breyer; K. Hucke; D. Gaefke; K. Schmeer
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- French
- Weight
- 479 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0022-2135
- DOI
- 10.1002/jlcr.814
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
S Pounds [PerkinElmer Life and Analytical Sciences, Inc., USA]—Preparation of carrier – free [Methyl‐^3^H] Methyl Nosylate and its Use as a Radiochemically Stable Methylating reagent.
DJ Wilkinson, AN Mather, MJ Hickey, LP Kingston [Astra Zeneca, UK]—Tritio‐Dehalogenation: New Variants on an Old Theme.
VG Sidorov, YB Zverkov, NF Myasoedov, IMG, Russia; IL Karpenko, EA Shirokova, DM Yanvarev, MV Yasko, YS Skoblov [EIMB, Russia], AB Susan, [IICH, USA]—The Syntheses of Labeled 3 ‘‐Azido‐3’‐Deoxythymidine Derivatives Displaying Anti‐HIV Activity.
NF Myasoedov, IY Nagaev, VP Shevchenko [IMG, Russia], AB Susan [IICH, USA], G Rotert [Abbott, USA]—Synthesis of Radiolabeled [^3^H]ABT‐578 for ADME Studies.
J Krueger, E Linnemann, G Fels [University of Paderborn, Germany]—(‐)‐[^3^H]Galanthamine – Labelling, Derivatization, and Application as Photoaffinity Probe.
F Wuest [Research Centre Rossendorf, Germany]—Carbon‐11 Labeled Compounds in the Development of Pharmaceuticals.
P Maeding, J Zessin, F Wüst [Research Centre Rossendorf, Germany], U Pleiss [Bayer HealthCare AG, Germany]—^11^C‐Labeling of a Taxane Derivative by [1‐^11^C] Acetylation.
J Bloom [Amersham Biosciences, UK]—The Preparation of 2‐Methyl [ring‐2‐^14^C] benzyl chloride.
V Derdau, R Oekonomopulos, G Schubert, H Heitsch [Aventis Pharma Deuschland GmbH, Germany]—Synthesis of ^14^C Labeled Angiotensin‐(1‐7)‐Receptor Agonist AVE 0991.
H Andres, P Burtscher, Y Metz, T Moenius [Novartis Pharma AG, Switzerland]—C‐14 Labeling of the β‐Amino Carboxyl Moiety–Alternatives to the Acrylate Approach.
F Kaegi, Y Metz, I Rodriguez, R Ruetsch [Novartis Pharma AG, Switzerland]—Effective Carbon‐14 Labelling under Microwave Irradiation.
CGM Janssen, B Verreet, HAC Lenoir, JBA Thijssen [Johnson & Johnson, Belgium]—Stable Isotope Labeled Compounds as Internal Standards for LC‐MS/MS, Requirements and Some Synthetic Approaches.
RP Stuerm [SafPro AG, Switzerland]—Models for Calculating the Radiation Dose after Incorporation of ^3^H and ^14^C.
A. Krins [VKTA Nuclear Engineering and Analytics e.V., Germany]—Dosimetry of C‐14 Labeled Organic Compounds.
E Rausch [Raytest GmbH, Germany], M Breyer, K Hucke, D Gaefke, K Schmeer [Bayer HealthCare AG, Germany]—A New Option of ^14^C‐Detection in Combination with Micro HPLC.
📜 SIMILAR VOLUMES
## Abstract **V Snieckus** [Queen's University, Canada]—__The Directed Ortho Metalation__—__Cross Coupling Symbiosis in Aromatic Synthesis__. **N Geach**, **GP Randall**, **CJ Winfield** [Scynexis, UK]—__Isotopically Labelled 4‐Formylimidazole__. **A Studer** [Marburg University, Germany]—__New C
Recent developments in the area of dearomatising cyclisation include the dearomatisation of 5-and 6-membered heterocycles 10,11 and the stereospecific photochemical rearrangement of the enolate products of the cyclisation to yield norcaradiene and cycloheptadienone ring systems. 12 We have also used
The general treatment paradigm in modern medicine has shifted from a 'one size fits all' approach towards an individualized patient based therapy. An efficient targeted therapy approach requires powerful diagnostic imaging tools in order to: detect a disease early; to stratify the patient's persona
work in our laboratories has focused on developing simple conditions for insertion of isotopically useful 'X' moieties into organic substrates ('R') of value to society. The overall concept is illustrated for biologically important radioisotopes but the corresponding stable isotopes have also been i